Showing results (101-110 of 331) with videos related to
Sort By:
Pageof 34
Oncoimmunology|July 29, 2016
Melanoma driver mutations and immune therapyDouglas B Johnson, Christine M Lovly, Ryan J Sullivan, et al.Journal for Immunotherapy of Cancer|May 9, 2019
Tumor genomic alterations in severe-combined immunodeficiency bare-lymphocyte syndrome genes are associated with high mutational burden and disproportional neo-antigen ratesYu Wang, Douglas B Johnson, Steve Lu, et al.Cancer|May 29, 2020
Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanomaJames R Patrinely, Laura X Baker, Elizabeth J Davis, et al.The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2026
A Multidisciplinary Approach to Checkpoint Inhibitor Adverse ReactionsCourtney N Andrews, Eric M Mukherjee, Andrew Gibson, et al.Cancer Immunology Research|May 20, 2016
Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent PembrolizumabAmanda Shreders, Richard Joseph, Chengwei Peng, et al.The Oncologist|May 12, 2020
Immune Checkpoint Inhibitor-Associated Primary Adrenal Insufficiency: WHO VigiBase Report AnalysisVirginie Grouthier, Bénédicte Lebrun-Vignes, Melissa Moey, et al.Case Reports in Oncological Medicine|October 21, 2014
Adult neuroblastoma complicated by increased intracranial pressure: a case report and review of the literaturePatrick L Stevens, Douglas B Johnson, Mary Ann Thompson, et al.Cancers|July 13, 2024
Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort StudyRachel S Goodman, Seungyeon Jung, Kylie Fletcher, et al.European Journal of Cancer (Oxford, England : 1990)|March 15, 2021
Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature reviewLee S Nguyen, Sofia Ortuno, Bénédicte Lebrun-Vignes, et al.Journal for Immunotherapy of Cancer|January 21, 2017
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinomaKathryn E Beckermann, Pradeep C Jolly, Ju Y Kim, et al.Pageof 34